지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2015.12
- 수록면
- 101 - 105 (5page)
이용수
초록· 키워드
오류제보하기
Purpose: C-reactive protein (CRP) has been identified to be associated with cancer development and progression. However, the role of CRP in tumor recurrence is less well defined in biliary tract cancer. Therefore, the aim of this study was to determine the clinical importance of CRP in terms of recurrence of biliary tract cancer after surgical resection.
Methods: Sevent-six patients who underwent curative resection for biliary tract cancer from April 2006 to July 2014 were reviewed. Demographics and tumor characteristics were evaluated retrospectively by review of a clinical database and review of pathologic reports.
Results: The study group was comprised of 48 men and 28 women, with a mean age of 62.2±10.8 years. Clinical diagnoses of these patients included intrahepatic cholangiocarcinoma (n=6), hilar cholangiocarcinoma (n=13), extrahepatic cholangiocarcinoma (n=21), gall bladder cancer (n=11), and ampullary cancer (n=25). Median follow-up was 35 months. Recurrence-free survival at 1-, 2-, and 5-year was 89%, 76%, and 53%, respectively. On univariate analysis, high CRP level (>3.0 mg/dL) was a significant risk factors for recurrence. Multivariate analysis showed high CRP, poor tumor differentiation, vascular invasion were independent risk factor for tumor recurrence.
Conclusion: Preoperative CRP level is significantly associated with recurrence in patients with biliary tract cancer, suggesting the possibility of using CRP as an independent prognostic indicator for biliary cancer.
Methods: Sevent-six patients who underwent curative resection for biliary tract cancer from April 2006 to July 2014 were reviewed. Demographics and tumor characteristics were evaluated retrospectively by review of a clinical database and review of pathologic reports.
Results: The study group was comprised of 48 men and 28 women, with a mean age of 62.2±10.8 years. Clinical diagnoses of these patients included intrahepatic cholangiocarcinoma (n=6), hilar cholangiocarcinoma (n=13), extrahepatic cholangiocarcinoma (n=21), gall bladder cancer (n=11), and ampullary cancer (n=25). Median follow-up was 35 months. Recurrence-free survival at 1-, 2-, and 5-year was 89%, 76%, and 53%, respectively. On univariate analysis, high CRP level (>3.0 mg/dL) was a significant risk factors for recurrence. Multivariate analysis showed high CRP, poor tumor differentiation, vascular invasion were independent risk factor for tumor recurrence.
Conclusion: Preoperative CRP level is significantly associated with recurrence in patients with biliary tract cancer, suggesting the possibility of using CRP as an independent prognostic indicator for biliary cancer.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
A study of biliary microbiota in patients with biliary tract disease
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Conversion surgery for initially unresectable extrahepatic biliary tract cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .08
-
Relationship between biliary tract cancer and coffee consumption in urban population
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: A population-based study
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Differences in Prognostic Factors between Early and Late Recurrence Breast Cancers
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Clinical significance of C-reactive protein-to-prealbumin ratio in predicting early recurrence in resectable pancreatic cancer
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2023 .06
-
Liquid biopsy from bile-circulating tumor DNA in patients with biliary tract cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
MicroRNA 141 Expression Is a Potential Prognostic Marker of Biliary Tract Cancers
Gut and Liver
2016 .01
-
Conversion surgery following neoadjuvant therapy for advanced biliary tract cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Identifying Predictive Factors for the Recurrence of Pediatric Intussusception
Pediatric Gastroenterology, Hepatology & Nutrition
2019 .01
-
C-reactive Protein Overexpression in the Background Liver of Hepatitis B Virus–Associated Hepatocellular Carcinoma Is a Prognostic Biomarker
Journal of Pathology and Translational Medicine
2018 .01
-
Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
Gut and Liver
2019 .01
-
Genetic aberration from normal tissues adjacent to biliary tract cancers
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Risk Factors and Tumor Recurrence in pT1N0M0 Gastric Cancer after Surgical Treatment
Journal of Gastric Cancer
2016 .01
-
Clinical outcomes and prognostic analysis of conversion surgery for initially unresectable biliary tract cancer: Japan-Korea collaboration study
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Preoperative biliary drainage for pancreatic cancer
International Journal of Gastrointestinal Intervention
2018 .01
-
Risk factors of recurrence in TNM stage I colorectal cancer
Annals of Surgical Treatment and Research
2023 .05
-
Validation for models for tumor recurrence after liver transplantation in hepatectomy patients
Annals of Surgical Treatment and Research
2022 .03
-
[Hepato-Biliary and Pancreas] Impact of Volumetric Parameters on 18F-FDG PET-CT in Pancreatic and Biliary Tract Cancer
대한외과학회 학술대회 초록집
2021 .11
-
A long-term survival case of advanced biliary cancer with repeated resection due to recurrence in the pancreaticogastrostomy site after pancreaticoduodenectomy
Annals of Hepato-Biliary-Pancreatic Surgery
2018 .05
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2016-513-002430312